Left Ventricular Reverse Remodeling in Long-Term (>12 Years) Survivors With Idiopathic Dilated Cardiomyopathy

被引:35
作者
Matsumura, Yoshihisa [1 ]
Hoshikawa-Nagai, Eri [1 ]
Kubo, Toru [1 ]
Yamasaki, Naohito [1 ]
Furuno, Takashi [1 ]
Kitaoka, Hiroaki [1 ]
Takata, Jun [2 ]
Sugiura, Tetsuro [3 ]
Doi, Yoshinori [1 ]
机构
[1] Kochi Univ, Dept Med & Geriatr, Kochi 780, Japan
[2] Kochi Univ, Ctr Promote Creat Med Educ, Kochi 780, Japan
[3] Kochi Univ, Kochi Med Sch, Dept Lab Med, Kochi 780, Japan
关键词
PAST; 20; YEARS; HEART-FAILURE; SYSTOLIC DYSFUNCTION; CLINICAL-OUTCOMES; OF-CARDIOLOGY; PROGNOSIS; CONJUNCTION; IMPROVEMENT; PREVALENCE; PREDICTORS;
D O I
10.1016/j.amjcard.2012.08.056
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Little is known about left ventricular (LV) reverse remodeling (LVRR) in long-term survivors with idiopathic dilated cardiomyopathy. We studied 59 patients with idiopathic dilated cardiomyopathy who had a potential clinical and echocardiographic follow-up period of >12 years. LVRR was defined as LV end-diastolic dimension <= 55 mm and fractional shortening >= 25% on the last echocardiogram. Of the 59 patients, 38 died (heart failure in 20, sudden death in 11, and other causes in 7), 2 underwent transplantation, and 19 survived. In the survivors, the LV size had significantly decreased and LV fractional shortening had significantly increased on the last echocardiogram. LVRR occurred in 37% of the survivors. The remaining 63% of the survivors still had LV dysfunction, but the LV end-systolic dimension had decreased significantly. In patients who died or underwent transplantation, the LV size significantly increased. No patient who died or underwent transplantation had LVRR. In conclusion, >60% of the long-term (>12 years) survivors with idiopathic dilated cardiomyopathy still had LV systolic dysfunction, but the LV end-systolic dimension had decreased significantly. In contrast, patients who died or underwent transplantation had significant LV enlargement. These results suggest that LVRR, even if it is not marked, is associated with a favorable prognosis. (c) 2013 Elsevier Inc. All rights reserved. (Am J Cardiol 2013;111:106-110)
引用
收藏
页码:106 / 110
页数:5
相关论文
共 23 条
[11]   Reliability of ventricular remodeling as a surrogate for use in conjunction with clinical outcomes in heart failure [J].
Konstam, MA .
AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (06) :867-871
[12]   Left Ventricular Remodeling in Heart Failure Current Concepts in Clinical Significance and Assessment [J].
Konstam, Marvin A. ;
Kramer, Daniel G. ;
Patel, Ayan R. ;
Maron, Martin S. ;
Udelson, James E. .
JACC-CARDIOVASCULAR IMAGING, 2011, 4 (01) :98-108
[13]   Quantitative Evaluation of Drug or Device Effects on Ventricular Remodeling as Predictors of Therapeutic Effects on Mortality in Patients With Heart Failure and Reduced Ejection Fraction A Meta-Analytic Approach [J].
Kramer, Daniel G. ;
Trikalinos, Thomas A. ;
Kent, David M. ;
Antonopoulos, George V. ;
Konstam, Marvin A. ;
Udelson, James E. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (05) :392-406
[14]   Improvement in prognosis of dilated cardiomyopathy in the elderly over the past 20 years [J].
Kubo, Toru ;
Matsumura, Yoshihisa ;
Kitaoka, Hiroaki ;
Okawa, Makoto ;
Hirota, Takayoshi ;
Hamada, Tomoyuki ;
Hitomi, Nobuhiko ;
Hoshikawa, Eri ;
Hayato, Kayo ;
Shimizu, Yuji ;
Yamasaki, Naohito ;
Yabe, Toshikazu ;
Nishinaga, Masanori ;
Takata, Jun ;
Doi, Yoshinori .
JOURNAL OF CARDIOLOGY, 2008, 52 (02) :111-117
[15]   Recommendations for chamber quantification: A report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology [J].
Lang, RM ;
Bierig, M ;
Devereux, RB ;
Flachskampf, FA ;
Foster, E ;
Pellikka, PA ;
Picard, MH ;
Roman, MJ ;
Seward, J ;
Shanewise, JS ;
Solomon, SD ;
Spencer, KT ;
Sutton, MS ;
Stewart, WJ .
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2005, 18 (12) :1440-1463
[16]   Reversal of heart failure remodeling: Is it maintained? [J].
Levine, TB ;
Levine, AB ;
Bolenbaugh, J ;
Green, PR .
CLINICAL CARDIOLOGY, 2003, 26 (09) :419-423
[17]  
MacGregor John F, 2009, Congest Heart Fail, V15, P5, DOI 10.1111/j.1751-7133.2008.00038.x
[18]   Long-term prognosis of dilated cardiomyopathy revisited - An improvement in survival over the past 20 years [J].
Matsumura, Y ;
Takata, J ;
Kitaoka, H ;
Kubo, T ;
Baba, Y ;
Hoshikawa, E ;
Hamada, T ;
Okawa, M ;
Hitomi, N ;
Sato, K ;
Yamasaki, N ;
Yabe, T ;
Furuno, T ;
Nishinaga, M ;
Doi, Y .
CIRCULATION JOURNAL, 2006, 70 (04) :376-383
[19]   Revised Equations for Estimated GFR From Serum Creatinine in Japan [J].
Matsuo, Seiichi ;
Imai, Enyu ;
Horio, Masaru ;
Yasuda, Yoshinari ;
Tomita, Kimio ;
Nitta, Kosaku ;
Yamagata, Kunihiro ;
Tomino, Yasuhiko ;
Yokoyama, Hitoshi ;
Hishida, Akira .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (06) :982-992
[20]   Prevalence and Prognostic Significance of Left Ventricular Reverse Remodeling in Dilated Cardiomyopathy Receiving Tailored Medical Treatment [J].
Merlo, Marco ;
Pyxaras, Stylianos A. ;
Pinamonti, Bruno ;
Barbati, Giulia ;
Di Lenarda, Andrea ;
Sinagra, Gianfranco .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (13) :1468-1476